DXCM as of Nov 1 · 23:19 ET
DXCMNasdaqSurgical & Medical Instruments & Apparatus

DexCom Inc · Brief

Next report

101 days

Feb 11 · after closeest.Q4 FY26

Expected move

No implied move.

Implied vs realized

8 reportsHistory
4 of 8≥ implied
avg implied
±8.7%
avg realized
±8.9%
Feb 13 '25±7.8%▲+5.92%×0.76
May 1 '25±9.4%▲+16.17%×1.72
Jul 30 '25±8.4%▼−9.31%×1.11
Oct 30 '25±12.6%▼−14.63%×1.16
Feb 12 '26±9.3%▲+7.59%×0.81
Q1 FY26±8.9%▲+3.02%×0.34
Q2 FY26±6.2%▲+11.95%×1.92
Q3 FY26±6.7%▲+2.95%×0.44
quarterimplied−20%0+20%realized×
Q3 FY26±6.7%▲+2.95%×0.44
Q2 FY26±6.2%▲+11.95%×1.92
Q1 FY26±8.9%▲+3.02%×0.34
Feb '26±9.3%▲+7.59%×0.81
Oct '25±12.6%▼−14.63%×1.16
Jul '25±8.4%▼−9.31%×1.11
2 older reports
May '25±9.4%▲+16.17%×1.72
Feb '25±7.8%▲+5.92%×0.76
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Feb 11 report · est.

—

Linked exposure

DXCM report session
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 15impliedImplied move: ±8.4% into Oct 29 earnings (Oct 15 close).Source
Oct 7report dateEarnings date confirmed: Oct 29, after close.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.